Therapeutic Goods Amendment Regulations 2009 (No. 1)

Overview

The Therapeutic Goods Act 1989, enacted to establish a comprehensive regulatory framework governing the quality, safety, efficacy, and timely availability of therapeutic goods within Australia and those exported from the country, aims to address significant public health concerns by ensuring that therapeutic products meet rigorous standards. The Therapeutic Goods Administration (TGA), under the Department of Health and Ageing, administers the Act and its associated regulations. In 2009, the Therapeutic Goods Amendment Regulations 2009 (No. 1) were introduced to amend the Therapeutic Goods Regulations 1990, removing restrictions on the reappointment of members of the Medical Devices Evaluation Committee beyond three consecutive terms. This adjustment allows for continuity in the committee's expertise until broader revisions to advisory committee arrangements are implemented. Additionally, the Regulations update the name of a body eligible to nominate an observer to the Therapeutic Goods Advertising Code Council, reflecting the recent name change from the Cosmetics, Toiletries and Fragrances Association of Australia to ACCORD Australasia Ltd. Consultation with relevant stakeholders, including the Medical Devices Evaluation Committee, ACCORD Australasia Ltd, and the Therapeutic Goods Advertising Code Council, has been conducted to facilitate these amendments.

Scope and Application

The Therapeutic Goods Act 1989, administered by the Therapeutic Goods Administration (TGA), establishes controls for the quality, safety, efficacy, and timely availability of therapeutic goods in Australia and for goods exported from Australia. This Act applies to a wide range of entities, including manufacturers, importers, and suppliers of therapeutic goods, and covers a broad spectrum of therapeutic goods, from medicines and medical devices to cosmetics and blood products. The Act has a national reach, applying across the Commonwealth of Australia, and is supplemented by regulations which may further define the scope and application of the Act. The Therapeutic Goods Amendment Regulations 2009 (No. 1) provide specific amendments, such as allowing members of the Medical Devices Evaluation Committee to be appointed for more than three consecutive terms, and updating the name of an observer body to the Therapeutic Goods Advertising Code Council from the Cosmetics, Toiletries and Fragrances Association of Australia to ACCORD Australasia Ltd. These regulations serve to maintain the composition of advisory committees until broader changes are introduced and reflect changes in the nomenclature of industry associations. The Act itself does not specify conditions that must be met before the power to make regulations can be exercised, and the regulations are subject to the Legislative Instruments Act 2003.

Key Provisions

The main operative sections of the Therapeutic Goods Amendment Regulations 2009 (No. 1) pertain primarily to amendments of the Therapeutic Goods Regulations 1990. Section 1 of the Regulations removes the restriction on the members of the Medical Devices Evaluation Committee being appointed for more than three consecutive terms, thereby allowing for continuity in the committee's operations. This amendment is in place until broader changes to the advisory committee arrangements are introduced. Additionally, Section 2 of the Regulations updates the reference to the body that may nominate an observer to the Therapeutic Goods Advertising Code Council, changing the name from the Cosmetics, Toiletries and Fragrances Association of Australia to ACCORD Australasia Ltd. These changes reflect the recent name change of the association and ensure that the correct entity is recognised for nomination purposes. The obligations imposed by the Regulations on the parties and entities they govern are relatively straightforward. Members of the Medical Devices Evaluation Committee, who may now be reappointed for more than three consecutive terms, must continue to fulfil their roles in evaluating medical devices until the broader advisory committee arrangements are revised. The Therapeutic Goods Administration (TGA) is responsible for administering these changes and ensuring that the committee's composition remains appropriate. Similarly, ACCORD Australasia Ltd, now recognised as the entity eligible to nominate an observer to the Therapeutic Goods Advertising Code Council, must ensure that any nominated observers are qualified and that their participation aligns with the Council's objectives. Breaches of the Therapeutic Goods Act 1989 and its associated regulations can result in significant civil or criminal penalties. The Act itself does not specify particular offences or penalties within the Regulations, but it does provide for general penalties under its own provisions. For instance, contravening the Act can lead to substantial fines, imprisonment, or both, depending on the severity of the offence. The Act empowers courts to impose penalties that reflect the seriousness of the breach, with maximum penalties varying according to the specific contravention. In the context of the Regulations, ensuring compliance with the updated provisions is crucial to avoid any potential legal repercussions associated with the Therapeutic Goods Act.